Skip To Main Content
Jonathan Zipursky on Muck Rack

Jonathan Zipursky

As seen in: British Pharmacological Society, BMJ Quality & Safety, The Globe and Mail, JAMA (The Journal of the American Medical Association), JAMA Internal Medicine Author Interviews, The New England Journal of Medicine, Canadian Medical Association Journal, Waterloo Region Record, Toronto.com, Brampton Guardian and
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Jonathan

Contact Jonathan, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Acetaminophen in pregnancy

|
By Jonathan Zipursky, Tali Bogler, Rachela Smith
| Canadian Medical Association Journal Verified
Acetaminophen is the preferred analgesic and antipyretic agent for pregnant people More than half of pregnant people use acetaminophen, most commonly for pain.1 Compared with alternatives, acetaminophen is the best studied analgesic and antipyretic in pregnancy and has the most reassuring maternal and fetal safety profiles.
Open in Who Shared Issue with article?

Infant deaths in the EudraVigilance database

|
By David Juurlink, Jonathan Zipursky
| British Pharmacological Society
LETTER TO THE EDITOR Infant deaths in the EudraVigilance database David N. Juurlink, Corresponding Author David N. Juurlink Divisions of General Internal Medicine and of Clinical Pharmacology and Toxicology, Sunnybrook Health Sciences Centre, and the Department of Medicine, University of Toronto, Toronto, Canada Search for more papers by this author Jonathan S. Zipursky, Jonathan S.
Open in Who Shared Issue with article?

Severe myelosuppression and alopecia after thiopurine initiation in a patient with NUDT15 deficiency

|
By Annie Wu Verified, Lee Mozessohn, Richard Kim Verified, Jonathan Zipursky
| British Pharmacological Society
1 INTRODUCTION Thiopurines are a class of immunosuppressant and antineoplastic agents that include mercaptopurine, azathioprine (prodrug of mercaptopurine) and thioguanine. They are widely used in treating inflammatory bowel disease, haematological malignancies, autoimmune diseases and various dermatological conditions.1 However, thiopurines are associated with significant adverse drug reactions, and 15–40% of patients will discontinue treatment due to intolerance.
Open in Who Shared Issue with article?
See all 59 licensed articles (60 Total)